Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05744856Not ApplicableCompleted

A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam

Role: lead

NCT06637683Not ApplicableCompleted

Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)

Role: collaborator

NCT05804123Not ApplicableCompleted

LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media

Role: collaborator

NCT05984004Not ApplicableCompleted

Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

Role: collaborator

NCT05602441Not ApplicableUnknown

Living Together With Chronic Disease: Informal Support for Diabetes Management in Vietnam (VALID)

Role: lead

All 5 trials loaded